Kounatidis, D.C.; Vallianou, N.G.; Panagopoulos, F.; Bampiolakis, A.; Stamatopoulos, V.; Dalamaga, M.; Mourouzis, I.; Pantos, C.
Revisiting the Lipid–Cancer Axis: PCSK9, ANGPTL3, and CETP as Emerging Biomarkers and Therapeutic Targets in Oncology. Biomolecules 2026, 16, 831.
https://doi.org/10.3390/biom16060831
AMA Style
Kounatidis DC, Vallianou NG, Panagopoulos F, Bampiolakis A, Stamatopoulos V, Dalamaga M, Mourouzis I, Pantos C.
Revisiting the Lipid–Cancer Axis: PCSK9, ANGPTL3, and CETP as Emerging Biomarkers and Therapeutic Targets in Oncology. Biomolecules. 2026; 16(6):831.
https://doi.org/10.3390/biom16060831
Chicago/Turabian Style
Kounatidis, Dimitris C., Natalia G. Vallianou, Fotis Panagopoulos, Antonios Bampiolakis, Vasileios Stamatopoulos, Maria Dalamaga, Iordanis Mourouzis, and Constantinos Pantos.
2026. "Revisiting the Lipid–Cancer Axis: PCSK9, ANGPTL3, and CETP as Emerging Biomarkers and Therapeutic Targets in Oncology" Biomolecules 16, no. 6: 831.
https://doi.org/10.3390/biom16060831
APA Style
Kounatidis, D. C., Vallianou, N. G., Panagopoulos, F., Bampiolakis, A., Stamatopoulos, V., Dalamaga, M., Mourouzis, I., & Pantos, C.
(2026). Revisiting the Lipid–Cancer Axis: PCSK9, ANGPTL3, and CETP as Emerging Biomarkers and Therapeutic Targets in Oncology. Biomolecules, 16(6), 831.
https://doi.org/10.3390/biom16060831
